These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19415232)

  • 1. Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals.
    Lim SC; Liu JJ; Low HQ; Morgenthaler NG; Li Y; Yeoh LY; Wu YS; Goh SK; Chionh CY; Tan SH; Kon YC; Soon PC; Bee YM; Subramaniam T; Sum CF; Chia KS
    Diabetologia; 2009 Jul; 52(7):1343-51. PubMed ID: 19415232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between common functional polymorphisms of the p22phox gene (-930A > G and +242C > T) and nephropathy as a result of Type 2 diabetes in a Chinese population.
    Lim SC; Goh SK; Lai YR; Tee WW; Koh A; Xu XH; Wu YS; Yap E; Subramaniam T; Sum CF
    Diabet Med; 2006 Sep; 23(9):1037-41. PubMed ID: 16922713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KCNQ1 SNPS and susceptibility to diabetic nephropathy in East Asians with type 2 diabetes.
    Lim XL; Nurbaya S; Salim A; Tai ES; Maeda S; Nakamura Y; Ng DP
    Diabetologia; 2012 Sep; 55(9):2402-6. PubMed ID: 22696034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians.
    Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Sud K; Bhansali A; Khullar M
    Mol Cell Biochem; 2008 Jul; 314(1-2):9-17. PubMed ID: 18401556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identified single-nucleotide polymorphisms and haplotypes at 16q22.1 increase diabetic nephropathy risk in Han Chinese population.
    Liao LN; Chen CC; Wu FY; Lin CC; Hsiao JH; Chang CT; Kardia SL; Li TC; Tsai FJ
    BMC Genet; 2014 Oct; 15():113. PubMed ID: 25359423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between INSR and MTOR polymorphisms in type 2 diabetes mellitus and diabetic nephropathy in a Northeast Chinese Han population.
    Zhu AN; Yang XX; Sun MY; Zhang ZX; Li M
    Genet Mol Res; 2015 Mar; 14(1):1808-18. PubMed ID: 25867326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of AMP-activated protein kinase subunit alpha 2 (PRKAA2) genetic polymorphisms on susceptibility to type 2 diabetes mellitus and diabetic nephropathy in a Chinese population.
    Li Q; Li C; Li H; Zeng L; Kang Z; Mao Y; Tang X; Zheng P; He L; Luo F; Li Z
    J Diabetes; 2018 Jan; 10(1):43-49. PubMed ID: 28322508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication study for the association of 3 SNP loci identified in a genome-wide association study for diabetic nephropathy in European type 1 diabetes with diabetic nephropathy in Japanese patients with type 2 diabetes.
    Maeda S; Imamura M; Kurashige M; Araki S; Suzuki D; Babazono T; Uzu T; Umezono T; Toyoda M; Kawai K; Imanishi M; Hanaoka K; Maegawa H; Uchigata Y; Hosoya T
    Clin Exp Nephrol; 2013 Dec; 17(6):866-71. PubMed ID: 23543049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
    Bailey JNC; Palmer ND; Ng MCY; Bonomo JA; Hicks PJ; Hester JM; Langefeld CD; Freedman BI; Bowden DW
    Hum Genet; 2014 Jun; 133(6):769-779. PubMed ID: 24385048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication study for the association between four Loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes.
    Maeda S; Araki S; Babazono T; Toyoda M; Umezono T; Kawai K; Imanishi M; Uzu T; Watada H; Suzuki D; Kashiwagi A; Iwamoto Y; Kaku K; Kawamori R; Nakamura Y
    Diabetes; 2010 Aug; 59(8):2075-9. PubMed ID: 20460425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus.
    Vieira SM; Monteiro MB; Marques T; Luna AM; Fortes MA; Nery M; Queiroz M; Dib SA; Vendramini MF; Azevedo MJ; Canani LH; Parisi MC; Pavin EJ; Giannella-Neto D; Corrêa-Giannella ML
    BMC Med Genet; 2011 Sep; 12():129. PubMed ID: 21962117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes.
    Kurashige M; Imamura M; Araki S; Suzuki D; Babazono T; Uzu T; Umezono T; Toyoda M; Kawai K; Imanishi M; Hanaoka K; Maegawa H; Uchigata Y; Hosoya T; Maeda S
    PLoS One; 2013; 8(1):e54064. PubMed ID: 23342076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population.
    Chen F; Li YM; Yang LQ; Zhong CG; Zhuang ZX
    IUBMB Life; 2016 Jul; 68(7):516-25. PubMed ID: 27192959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of nitric oxide and endothelin in end-stage renal disease.
    Freedman BI; Yu H; Anderson PJ; Roh BH; Rich SS; Bowden DW
    Nephrol Dial Transplant; 2000 Nov; 15(11):1794-800. PubMed ID: 11071967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
    Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M
    DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism.
    Zanchi A; Moczulski DK; Hanna LS; Wantman M; Warram JH; Krolewski AS
    Kidney Int; 2000 Feb; 57(2):405-13. PubMed ID: 10652017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a SNP map of 6q24-27 confirms diabetic nephropathy loci and identifies novel associations in type 2 diabetes patients with nephropathy from an African-American population.
    Leak TS; Mychaleckyj JC; Smith SG; Keene KL; Gordon CJ; Hicks PJ; Freedman BI; Bowden DW; Sale MM
    Hum Genet; 2008 Aug; 124(1):63-71. PubMed ID: 18560894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes.
    Ahluwalia TS; Lindholm E; Groop LC
    Diabetologia; 2011 Sep; 54(9):2295-302. PubMed ID: 21573905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between the G82S Polymorphism of the Receptor Gene for Advanced Glycation End-products and Soluble Serum Levels RAGE with Diabetic Nephropathy in the White (Asian) Race.
    Rezaei Arnesa A; Hajian S; Salemi Bazargani S; Salahshourifar I; Moghbelinejad S; Abdolvahabi Z; Yaghoobzadeh H; Fathi M; Piri H
    Iran J Kidney Dis; 2024 May; 18(3):179-186. PubMed ID: 38904338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.